retatrutide clinical trial results obesity ⭐️topline from TRIUMPH-1, a Phase 3 evaluating #retatrutide, an investigational GIP / GLP-1 / glucagon triple hormone receptor agonist, in adults with or “overweight” Retatrutide Shows 28% Weight Loss
Description
'Doubling Up' on a Missed Dose: If you forget a dose, do not take two doses the next day to 'catch up.' This can spike the medication in your system and lead to intense nausea and other unpleasant side effects
Are GLP-1s safe
Current UK guidance from the MHRA, NICE, and manufacturers' product information consistently advises against using GLP-1 medications during lactation due to insufficient safety data
These 2 changes allowed semaglutide durability for up to 1 week and resulted in U.S
They mimic the action of a hormone called GLP-1, which interacts with the brain to suppress appetite and turn off cravings and hunger signals so individuals feel satisfied
New Workouts or Increased Movement Feeling better often leads to moving more
